Hybrid Conference


2021 World Dementia & Mental Health Conference

November 19-20, 2021

About 2021 World Dementia and Mental Health Conference

Memories Matter: Until there is a CARE there is HOPE!!


Download Our Brochure to know more

2021WDMH Goes Fully Virtual this March 2021

With COVID 19 pandemic has disrupted the normal life and the new normality has taken place, it has become very difficult for some participants to participate in the conference physically. Though we are very sure that due to vaccination drives taking place, till November it will be possible again to hold the physical conference but we don’t want any of our participants to miss out. Hence, 2021WDMH will have the option to participate virtually as well. 

2021WDMH is fully prepared to deliver online the unique interactive experience we offer each year at our physical meeting. We are determined that none of our international colleagues will miss out on any of the conference sessions, nor the opportunity to present his or her work to colleagues from all over the world. 

We hope you understand and support this move and look forward to welcoming you to the 2021WDMH Conference from Friday 19th November 2021 to Saturday 20th November 2021.

Theme: Memories Matter: Until there is a CARE there is HOPE!!

Episirus Scientifica would like to take the opportunity to announce the commencement of the 4th Edition of 2021 World Dementia and Mental Health Conference.

2021WDMH will provide a platform that brings together eminent neurologists, psychiatrists, psychologists, neuroscientists, and many more. The gathering incorporates prompt keynote sessions, symposiums, workshops/Special Session, and offers exceptional sessions, presentations with a great education and networking opportunities for all levels of academic professionals. And also, a great opportunity for the young researchers to share (oral/poster presentation) and a scope to learn from experiences shared by distinguished participants.

Scope and Importance

If considered on a global scale, around 50 million people have dementia, and there are nearly 10 million new cases every year. Dementia, a syndrome in which there is retrogression in memory, behaviour, thinking, and the ability to perform activities. It mainly affects older people and is one of the major causes of disability and dependency. It is important to understand what causes the diseases so that effective treatments can be developed and improved ways of providing care can be implemented. But in order to have progress in this research field, we need more researchers to take part and hopefully one day research will lead a way to find a cure.

The conference will gather participants from all across the globe to share their experiences and knowledge in the field of Dementia. Best networking will result in spreading awareness which delivers new opportunities for people to play their part in beating dementia. 


  • Dementia
  • Ageing and Depression
  • Neurodegenerative diseases: Alzheimer’s and Parkinson’s
  • Vascular Dementia
  • Clinical Neuroimaging
  • Psychiatry and Mental Health
  • Oncology and Dementia
  • Critical and Acute care
  • Brain Therapeutics
  • Ethical Dilemmas in Dementia

Target Audience 

  • Academic Professionals
  • R&D Researchers
  • Family and General Practitioners
  • Business Professional from the Health Care Sector
  • Medical and Health Services Managers
  • Neurologists
  • Psychiatrists
  • Psychologists
  • Psychiatric nurses
  • Psychotherapists
  • Graduates, Postgraduates & Ph.D. Scholars
  • Mental Health Professionals
  • Home Health Aides and Personal Care Aides

 Key Dates:

Why Bangkok, Thailand?

Thailand has long been a popular choice for conference meetings and events in Southeast Asia as it has been known for its legendary hospitality services. The vibrant capital city of Bangkok is a top and best destination for organizing international conferences. The newly opened Suvarnabhumi International Airport handles passengers over 40 million per year from the most major cities in Europe, Asia, and North America and connects the city via electric rail.

 Session 1: Dementia

Dementia is a collective general term for the loss of memory and other cognitive declines, such as forgetfulness. It is a symptom of several underlying brain disorders and diseases. Alzheimer’s disease is the most common cause of dementia, a continuous decline in behavioral, thinking, and social skills. The signs and symptoms such as memory problems, communication difficulties, changes in mood and behavior, difficulties with organizing and planning one’s day-to-day life, and the gradual loss of control of physical functions. 

  • Dementia, Prevention, and Treatments
  • Amnesia and dementia
  • Cognitive Impairment and Clinical Cases
  • Telegerontology
  • Young-onset dementia
  • Human interaction with technology in dementia
  • Cognitive stimulation therapy (CST)

Session 2: Ageing and Depression

Ageing is just a part of the life cycle, a person is born, goes through childhood, adolescence, and adulthood and, at a certain point in time, begins to age. Occasional lapses in memory that disrupts daily life is not a typical part of aging, it may be a symptom of dementia.

Depression is a common mental disorder characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life, feelings of guilt or low self-worth, decreased energy, disturbed sleep or appetite, and poor concentration.

  • Hypertension
  • Age Discrimination
  • Hypertension and aging-related cardiac and vascular dysfunctions
  • Gerontology
  • Normal Cognitive Aging
  • Prevalence of depression

Session 3: Neurodegenerative Diseases: Alzheimer’s and Parkinson’s

Neurodegenerative Diseases affect the central nervous system (CNS) causing progressive central nervous system dysfunction. It occurs when the peripheral nervous system or nerve cells in the brain lose function over time and ultimately die. The common types of neurodegenerative diseases are Alzheimer’s and Parkinson’s.

  • Clinical trials in Alzheimer’s disease
  • Protein Homeostasis, Aging and Alzheimer’s Disease
  • Human Neuropathology
  • Biomarkers (non-neuroimaging) Alzheimer
  • Role of Inflammatory Cells in Neurodegeneration
  • Microglial Cells in AD

Session 4: Vascular Dementia

Vascular Dementia is generally termed as a decline in reasoning, planning, judgment, memory, and other thought processes caused by conditions like stroke that reduce or impaired blood flow to various regions of the brain. Inadequate blood flow can damage and eventually kills the brain cells. Brain cells need a constant supply of blood to bring oxygen and nutrients, to be healthy and function properly. Blood is transferred to the brain through a network of vessels called the vascular system. 

  • Cerebrovascular disease and vascular dementia
  • Specific Risk Factors in Vascular Dementia: Diagnosis and Prevention
  • Subcortical Ischemic Vascular Dementia (SIVD)
  • Clinical Presentations and Epidemiology

Session 5: Clinical Neuroimaging 

Clinical Neuroimaging includes the use of various techniques to either directly or indirectly image the structure or function of the brain (such as computed tomography and magnetic resonance imaging). Magnetic resonance imaging (MRI) and functional magnetic resonance imaging (fMRI) scans are the forms of neuroimaging most directly useful to the field of neurology. MRI is the general standard imaging study, as it enables detection of the various neurodegenerative diseases (Alzheimer’s disease, frontotemporal degeneration, Lewy body dementia).

  • Neuroimaging Biomarkers for Alzheimer’s Disease
  • White matter hyperintensities (WMH)
  • The pattern of cognitive deficits
  • Pathophysiology and Pathobiology of vascular dementia

Session 6: Psychiatry and Mental Health

Psychiatry is the field of medicine focused on the diagnosis, treatment, and prevention of behavioral, emotional, and mental disorders. Psychiatric or mental disorders is a group of symptoms characterized by clinically significant disturbance in an individual’s cognition, behavior, or emotion that reflects a dysfunction within the psychological processes underlying mental function.

  • Psychiatry and Psychotherapy
  • Mental Health & Anxiety Disorders
  • Mental Health Care for LGBT Older Adults
  • Neuropsychiatry and Behavioral Neurology
  • Neuropsychology
  • Addiction Therapy

Session 7: Oncology and Dementia

Some studies have suggested that patients with dementia have a decreased risk of subsequently being diagnosed with cancer, and cancer patients have a lower risk of dementia. Dementia is usually preceded by cognitive impairment, during which pathophysiological processes underlying dementia may already be present. Since a shared pathology between cognitive problems and cancer has been hypothesized, a logical question emerges whether cancer and cancer treatment are also associated with an increased risk of dementia.

  • Androgen Deprivation Therapy Use
  • Cancer and Chemotherapy in patients with dementia
  • Prognostic factors for gastrectomy
  • Prostate Cancer ADT Raises Dementia Risk
  • Assessment and Screening of Delirium and Dementia

Session 8: Critical and Acute Care

  1. Better identification of cognitive impairment in hospitals
  2. Increased training for all staff including how to communicate with a person with dementia and how to respond to behavioral and psychological symptoms
  3. Systematic and more extensive involvement of caregivers as partners in the health care of people with dementia
  4. Creation of appropriate physical hospital environments to reduce distress and confusion of people with dementia.
  • Critical Illness in the Elderly
  • ICU and Dementia
  • Risk of Dementia after acute respiratory failure
  • Interventions to improve the care of people
  • Caring for Patients with Dementia in the Acute Care Environment

Session 9: Brain Therapeutics

Cognitive impairment is when an individual has trouble remembering, concentrating, learning new things, or making decisions that affect their everyday life. Cognitive disorders are caused due to hormonal imbalances in the womb, genetic predisposition, environmental factors and other common causes of the cognitive disorder include substance abuse and physical trauma.

  • Music as Therapy
  • Traumatic Brain Injury
  • Therapeutics for Vascular Cognitive Impairment and Dementia
  • Neuroprotective therapies
  • Non-invasive brain stimulation

Session 10: Ethical Dilemmas in Dementia

All the people working in dementia care face a difficult situation and have to take an ethical decision every day. It is very important for the Caregivers to balance the needs of their patients while considering patient privacy, the potential risk, and abuse, the benefits including medications, and procedures. If in case the patients are not able to make decisions and express their will, then their guardian or the designated decision-makers must step in to make the difficult decisions. 

  • Caregiving – Alzheimer’s & Dementia
  • Ethical Decision-Making
  • Advance Care Planning for People with Dementia
  • eHealth Interventions for Family Carers

For the Past Conference Report: Click Here


Panel Discussion


Session Talks


E-Poster Comeptition

Featured Talks & Speakers

Download our brochure to know more about the session talks to be presented at the live webinar. The exact timings will be released 30 days prior to the conference.

Our Organizing Committee Members


Dr. Retnaningsih


Dr. Ahmed Fouad


Dr. Moh Hasan Machfoed


Dr. Mohammed Naeem

Our Media Partners

cn new design 170x170
Technology Network Group are media partner of 2020 World Dementia and Mental Health Conference
Banner Summer Stroke School_2020.jpg
ESO-WSO 2020_banner_600x150
CR_Logo_Media Partner_Episirus.org
SVC Healthcare and Educational Management Services_Media Partner_Episirus.org
BSP_Logo_new_Episirus Scientifica_media-partner-300x289

Register Now!

Hurry ! the early bird registrations are going to close soon by July 30, 2021.

Contact Us